Postoperative Troponin in Children With Congenital Heart Disease

Cliniques universitaires Saint-Luc- Université Catholique de Louvain180 enrolled

Overview

The aim of the study is to evaluate the value of postoperative troponin in the prediction of mid term and long term mortality and morbidity in children with congenital heart disease undergoing cardiac surgery.

Study Type

OBSERVATIONAL

Enrollment

180

Conditions

Congenital Heart Disease

Eligibility

Sex: ALLMax age: 10 Years

Medical Language ↔ Plain English

Inclusion Criteria: * all children with congenital heart disease between 0-10 years admitted for elective or emergency corrective or palliative cardiac surgery Exclusion Criteria: * parental refusal * children older than 10 years

Locations (1)

Cliniques Universitaires saint Luc

Brussels, Belgium

Outcomes

Primary Outcomes

mortality

Time frame: 3 months

Secondary Outcomes

morbidity and mortality and length of stay in the PICU and in the hospital

Time frame: in hospital; 3 months; 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.